Skip to main content

Table 1 Primers and restriction enzymes used for the analysis of VEGF polymorphisms

From: Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

Primers

Restriction enzyme

Reference SNP

VEGF -1498 C/T

F:5'-TGT GCG TGT GGG GTT GAG CG

R:5'-TAC GTG CGG ACA GGG CCT GA

BstUI

rs833061

VEGF + 405 C/G

F:5'-ATT TAT TTT TGC TTG CCA TT

R:5'-GTC TGT CTG TCT GTC CGT CA

BsmFI

rs2010963

VEGF -2578 C/A

F:5'-GGC CTT AGG ACA CCA TAC C

R:5'-CAC AGC TTC TCC CCT ATC C

BstYI

rs699947

VEGF + 936 C/T

F:5'-AAG GAA GAG GAG ACT CTG CGC AGA GC

R:5'-TAA ATG TAT GTA TGT GGG TGG GTG TGT CAT CAG G

NlaIII

rs3025039